SCHEMBL1243769

SCHEMBL1243769

CCOC(=O)C(=CN(c1cc(F)c(F)c(F)c1)C(CC)CC)C(=O)OCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.40
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
LMNA P02545 5/20 0.40
NPSR1 Q6W5P4 5/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPK1 P28482 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GLO1 Q04760 1/20 0.34
S1PR4 O95977 1/20 0.34
S1PR1 P21453 1/20 0.34
GAA P10253 3/20 0.33
DHODH Q02127 3/20 0.33
TDP1 Q9NUW8 1/20 0.32
PLIN1 O60240 1/20 0.32
POLB P06746 1/20 0.32
PLIN5 Q00G26 1/20 0.32
ABHD5 Q8WTS1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4105036 0.83 RIPK1 (0.32)
SCHEMBL25069399 0.76 NPSR1 (0.40) MAPTMEN1KMT2ALMNANPSR1
SCHEMBL262000 0.74 MAPT (0.38) MAPTMEN1KMT2ALMNANPSR1
SCHEMBL1344820 0.72 NPSR1 (0.37) MAPTMEN1KMT2ALMNANPSR1
SCHEMBL4567542 0.70 CES2 (0.43) MAPTMEN1KMT2ALMNANPSR1
SCHEMBL10656978 0.70 KMT2A (0.42) MAPTMEN1KMT2ALMNANPSR1
SCHEMBL8624946 0.69 MAPT (0.43) MAPTMEN1KMT2ALMNANPSR1
SCHEMBL1345002 0.68 DHODH (0.61) MAPTMEN1KMT2ALMNANPSR1
SCHEMBL8645991 0.67 MEN1 (0.41) MAPTMEN1KMT2ALMNANPSR1
SCHEMBL9561731 0.67 MEN1 (0.40) MAPTMEN1KMT2ALMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7879878-B2 such as {2-[({[7-(cyclohexylamino)-6-fluoro-4-oxo-1-[(3S)-tetrahydrofuran-3-yl]-1,4-dihydroquinolin-3-yl}carbonyl)amino]ethyl}phosphonic acid, used as platelet aggregation inhibitor and purinergic receptor (P2Y12) inhibitors; therapy for circulatory diseases involving thrombosis via platelet aggregation ASTELLAS PHARMA INC. (JP) 2011-02-01 US disclosed